Friberg, Heather http://orcid.org/0000-0001-5173-2701
Gargulak, Morgan
Kong, Amanda
Lin, Leyi
Martinez, Luis J.
Schmidt, Alexander C.
Paris, Robert M.
Jarman, Richard G.
Diaz, Clemente
Thomas, Stephen J. http://orcid.org/0000-0002-8368-7682
Moris, Philippe
Currier, Jeffrey R. http://orcid.org/0000-0002-5696-0268
Article History
Received: 5 August 2021
Accepted: 8 September 2022
First Online: 31 October 2022
Competing interests
: H.F., L.L., L.J.M., R.G.J., S.J.T. and J.R.C. received financial and other support without any personal financial benefit from GSK as part of the Cooperative Research and Development Agreement (CRADA) between the US Army and GSK; they also receive travel support through the CRADA. A.C.S., R.M.P., and P.M. were employees of GSK and held shares in GSK at the time of study conduct. The institution of C.D. received funding from GSK and the US Army Medical Materiel Development Activity to conduct this study. H.F., L.L., L.J.M., A.C.S., R.M.P., R.G.J., C.D., S.J.T., P.M. and J.R.C. declare no other financial and non-financial relationships and activities. M.G. and A.K. declare no financial and non-financial relationships and activities and no conflicts of interest. The opinions or assertions contained herein are the private views of the authors and are not to be construed as reflecting the official views of the US Army or the US Department of Defense. The investigators have adhered to the policies for protection of human subjects as prescribed in AR 70-25. <i>Dengvaxia</i> is a trademark owned by or licensed to Sanofi Pasteur.